ExchangeDBV
DBV Technologies Reports September 30, 2020 Cash Position Paris Stock Exchange:DBV
Montrouge, France, October 30, 2020 DBV Technologies Reports September 30, 2020 Cash Position DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported its cash and cash equivalents and number of outstanding shares as of September 30, 2020. Cash and cash equivalents:Cash and cash equivalents as …
DBV Technologies Announces Leadership Changes Paris Stock Exchange:DBV
Montrouge, France, September 9, 2020 DBV Technologies Announces Leadership Changes DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Ramzi Benamar, Chief Financial Officer, and Kevin Trapp, Chief Commercial Officer, will be leaving the Company as of October 2, 2020. Sébastien Robitaille has been appointed …
